Lupin receives tentative USFDA approval, stock tops Nifty pharma
Lupin receives tentative USFDA approval, stock tops Nifty pharma

Lupin receives tentative USFDA approval, stock tops Nifty pharma

Bhagyashree Vivarekar Article rating: 5.0

Lupin, the sixth largest pharma company by market capitalisation, received tentative US FDA approval for its generic Lurasidone Tablets of 20, 40, 60, 80 and 120 mg. Lupin which holds 8.8 per cent weightage in the Nifty pharma index was the top gainer in the index and surged 5 per cent on a closing basis. 

Mid-cap, small-cap outperforms
Mid-cap, small-cap outperforms

Mid-cap, small-cap outperforms

Gayathri Udyawar Article rating: 5.0

The broad market indices BSE Mid-cap and Small-cap index registered handsome gains. The BSE Mid-cap index gained 0.62 per cent, while small-cap index was up by 1.37 per cent on Monday.

Benchmark indices bewildered, CPI and WPI moderately higher
Benchmark indices bewildered, CPI and WPI moderately higher

Benchmark indices bewildered, CPI and WPI moderately higher

Bhagyashree Vivarekar Article rating: 5.0

Continuing with the optimism shown on Friday, the Indian stock markets opened Monday’s session on a positive note but witnessed range-bound volatility during the day. Bounce back in the Indian rupee by 50 paise and Brent oil by 40 paise brought in some pessimism in the markets. The country reported WPI and CPI inflation. 

Glenmark Pharma gets USFDA approval for skin cream
Glenmark Pharma gets USFDA approval for skin cream

Glenmark Pharma gets USFDA approval for skin cream

Shohini Nath Article rating: 5.0

Glenmark Pharmaceuticals has been given a nod from the USFDA for Hydrocortisone Valerate Cream. The shares of the company went up by over 2 per cent.

 

Astron Paper & Board Mill commences production in PM-2 Gujarat
Astron Paper & Board Mill commences production in PM-2 Gujarat

Astron Paper & Board Mill commences production in PM-2 Gujarat

Pratik Shastri Article rating: 5.0

Astron Paper and Board Mill’s, company engaged in the manufacturing of Kraft Paper from waste paper, informed that its PM-2 located at Halvad, Gujarat has commenced commercial production of kraft paper, having installed capacity of 33,000 MT/year.

 

Is investment in interval mutual funds a good option?
Is investment in interval mutual funds a good option?

Is investment in interval mutual funds a good option?

Henil Shah Article rating: 5.0

Is upward movement of interest rates worrying you? Are you looking for some other options for attaining your short-term goals? Then maybe you should have a look at interval funds. Read on to know about interval funds.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on October 15, 2018 opened gap down. BSE Sensex is trading at 34,748.75, up by 15.17 points and the Nifty is trading at 10,468.55, down by 3.95 points. 

GSS Infotech surges on acquisition of US based company
GSS Infotech surges on acquisition of US based company

GSS Infotech surges on acquisition of US based company

Apurva Joshi Article rating: 4.5

GSS Infotech Inc, a wholly-owned subsidiary of GSS Infotech Limited, signed a share purchase agreement for acquiring 100 per cent shares of Nexii Labs Inc, USA. The latter company will become a wholly-owned step-down subsidiary of GSS Infotech Inc.

RSS
First31823183318431853187318931903191Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR